FI100556B - Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten - Google Patents
Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia vartenInfo
- Publication number
- FI100556B FI100556B FI950962A FI950962A FI100556B FI 100556 B FI100556 B FI 100556B FI 950962 A FI950962 A FI 950962A FI 950962 A FI950962 A FI 950962A FI 100556 B FI100556 B FI 100556B
- Authority
- FI
- Finland
- Prior art keywords
- drug
- dna
- detection
- antibodies
- solid phase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/104—Lupus erythematosus [SLE]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Saccharide Compounds (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI950962A FI100556B (fi) | 1995-03-01 | 1995-03-01 | Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten |
DE69621915T DE69621915T2 (de) | 1995-03-01 | 1996-02-29 | Anti-dns-antikörpernachweis mittels erkennung und bindung telomerischer dns-sequenzen |
NZ301725A NZ301725A (en) | 1995-03-01 | 1996-02-29 | Anti DNA antibody detection involving telomeric DNA sequence recognition and binding |
ZA961628A ZA961628B (en) | 1995-03-01 | 1996-02-29 | Diagnostic method test kit drug and therapeutic treatment for autoimmune diseases |
ES96903036T ES2175069T3 (es) | 1995-03-01 | 1996-02-29 | Deteccion de anticuerpos anti-dna que implica el reconocimiento y la union de secuencias telomericas de dna. |
AU47215/96A AU720912B2 (en) | 1995-03-01 | 1996-02-29 | Anti DNA antibody detection involving telomeric DNA sequence recognition and binding |
AT96903036T ATE219580T1 (de) | 1995-03-01 | 1996-02-29 | Anti-dns-antikörpernachweis mittels erkennung und bindung telomerischer dns-sequenzen |
EP96903036A EP0812421B1 (en) | 1995-03-01 | 1996-02-29 | Anti dna antibody detection involving telomeric dna sequence recognition and binding |
PCT/FI1996/000117 WO1996027131A1 (en) | 1995-03-01 | 1996-02-29 | Anti dna antibody detection involving telomeric dna sequence recognition and binding |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI950962A FI100556B (fi) | 1995-03-01 | 1995-03-01 | Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten |
Publications (3)
Publication Number | Publication Date |
---|---|
FI950962A0 FI950962A0 (fi) | 1995-03-01 |
FI950962A FI950962A (fi) | 1996-09-02 |
FI100556B true FI100556B (fi) | 1997-12-31 |
Family
ID=8542958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI950962A FI100556B (fi) | 1995-03-01 | 1995-03-01 | Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0812421B1 (fi) |
AT (1) | ATE219580T1 (fi) |
AU (1) | AU720912B2 (fi) |
DE (1) | DE69621915T2 (fi) |
ES (1) | ES2175069T3 (fi) |
FI (1) | FI100556B (fi) |
NZ (1) | NZ301725A (fi) |
WO (1) | WO1996027131A1 (fi) |
ZA (1) | ZA961628B (fi) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032610A1 (en) | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
US7018798B2 (en) * | 1997-08-12 | 2006-03-28 | Embedded Concepts, Llc | Nucleic acid antigens embedded in thermoplastic |
EP1274410A2 (en) * | 2000-03-31 | 2003-01-15 | Trustees Of Boston University | Use of locally applied dna fragments |
WO2005025650A1 (de) * | 2003-09-12 | 2005-03-24 | Frank Mattner | Apherese-vorrichtung |
SI24638A (sl) | 2014-02-04 | 2015-08-31 | Univerzitetni kliniÄŤni center Ljubljana | Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA |
WO2018190365A1 (ja) * | 2017-04-12 | 2018-10-18 | 国立大学法人九州大学 | 神経障害性疼痛マーカー及びその使用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE61670T1 (de) * | 1985-06-25 | 1991-03-15 | Progen Biotechnik Gmbh | Immuntest zum nachweis von antikoerpern gegen dns. |
AU1070588A (en) * | 1987-01-30 | 1988-08-04 | Diagnostic Products Corporation | Measuring anti-dna antibodies |
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
-
1995
- 1995-03-01 FI FI950962A patent/FI100556B/fi not_active IP Right Cessation
-
1996
- 1996-02-29 WO PCT/FI1996/000117 patent/WO1996027131A1/en active IP Right Grant
- 1996-02-29 ZA ZA961628A patent/ZA961628B/xx unknown
- 1996-02-29 DE DE69621915T patent/DE69621915T2/de not_active Expired - Lifetime
- 1996-02-29 ES ES96903036T patent/ES2175069T3/es not_active Expired - Lifetime
- 1996-02-29 NZ NZ301725A patent/NZ301725A/en unknown
- 1996-02-29 EP EP96903036A patent/EP0812421B1/en not_active Expired - Lifetime
- 1996-02-29 AT AT96903036T patent/ATE219580T1/de not_active IP Right Cessation
- 1996-02-29 AU AU47215/96A patent/AU720912B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ATE219580T1 (de) | 2002-07-15 |
EP0812421A1 (en) | 1997-12-17 |
DE69621915T2 (de) | 2003-01-23 |
ZA961628B (en) | 1996-08-08 |
DE69621915D1 (de) | 2002-07-25 |
AU4721596A (en) | 1996-09-18 |
AU720912B2 (en) | 2000-06-15 |
NZ301725A (en) | 2001-02-23 |
FI950962A0 (fi) | 1995-03-01 |
FI950962A (fi) | 1996-09-02 |
ES2175069T3 (es) | 2002-11-16 |
EP0812421B1 (en) | 2002-06-19 |
WO1996027131A1 (en) | 1996-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Uwatoko et al. | Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. | |
DE69520149D1 (de) | Tie-2 ligande, verfahren zu ihrer herstellung, und ihre anwendungen | |
NO982062D0 (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
DE69841170D1 (de) | Menschliche Toll-ähliche Rezeptorproteine, zugehörige Reagenzien und Verfahren | |
CA2082390A1 (en) | Dna encoding human 5-ht1d receptors and uses thereof | |
MY136224A (en) | Monkey monoclonal antibodies specific to human b7.1 and/or b7.2,primatized forms thereof,pharmaceutical compos itions containing, and use thereof as immunosuppressants | |
DE69333776D1 (de) | Dna codierend für den menschlichen 5-ht 1f rezeptor und ihre verwendung | |
FR2751986B1 (fr) | Gene implique dans le cadasil, methode de diagnostic et application therapeutique | |
ATE173544T1 (de) | Parvovirusrezeptoren und verfahren zur ihrer verwendung | |
DE68925226D1 (de) | Monoklonale Antikörper | |
WO2003072598A3 (en) | Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases | |
DE69233496D1 (de) | Dna kodierend für den menschlichen 5-ht 1e-rezeptor und seine verwendungen | |
ATE245190T1 (de) | Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung | |
FI100556B (fi) | Menetelmä anti-DNA-vasta-aineiden toteamiseksi, diagnostinen menetelmä , reagenssipakkaus ja lääkeaine autoimmuunisairauksia varten | |
WO1998006841A3 (en) | Two human nsp-like proteins | |
ATE277171T1 (de) | Ikk-alpha proteine, nukleinsäuren und verfahren | |
WO1997023611A3 (de) | Nukleinsäuresequenzen von genen der high mobility group proteine sowie verwendungen derselben | |
DE69020182D1 (de) | Vernetzte Antikörper und Verfahren zu ihrer Herstellung. | |
MXPA02005236A (es) | Metodos de tratamiento de lupus con base en la afinidad de anticuerpos y metodos de separacion por exclusion y composiciones para el uso de los mismos. | |
EP2128257A3 (fr) | Mutations du gene de la parkine, compositions, methodes et utilisations | |
DE69829995D1 (de) | Multivalente rekombinante antikörper zur behandlung von hrv infektionen | |
DK1128841T3 (da) | Farmaceutisk præparat indeholdende en receptorantagonist til behandling af blodkoagulationsforstyrrelser | |
HUP0101689A2 (hu) | Anti-gp39-ellenanyagok alkalmazása lupusz és ezzel asszociált vesebetegség kezelésére és/vagy visszafejlesztésére | |
EP1293570A3 (en) | Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) | |
WO2000049144A3 (en) | Pyk2 binding proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |